INTERVENTIONAL CARDIOLOGY

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

whitePaper | November 17, 2021

Nearly every healthcare provider has been hit by ransomware, and the onslaught continues unabated, now affecting patient care with once-unimaginable patient-care consequences. This whitepaper, crafted with healthcare CISOs, details seven critical areas to defend or recover from ransomware attacks. Its pragmatic approach helps ensure business operations and patient care while giving risk teams the tools to manage third parties and other systems involved in business and clinical value chains.

whitePaper | July 5, 2022

This whitepaper on atopic dermatitis patient recruitment explores the challenges faced by sponsors, CROs and study sites in enrolling sufficient numbers of patients for their clinical trials.

whitePaper | November 19, 2022

Now, more than ever, sponsors and CROs need to prioritize including patient engagement in their study builds from the ground-up. This involves defining processes to remove barriers for access.

whitePaper | November 20, 2019

This whitepaper examines the financial implications of an effective CRM system, without which your organization risks. To acquire and retain patients, health systems have to connect with their customers cost-effectively. And along the way, they need to detect and measure to what extent their marketing efforts are making an impact.

whitePaper | October 26, 2021

James Angle, Ph.D. of Trinity Health and Erin Logue Smith of Dell Technologies provided timely information on cybersecurity in a Healthcare Innovation webinar as ransomware threats makes it mandatory tosystematically elicit and mitigateprivacy threats in software architectures.